ACLS Provider: Course

Incorrect. High-quality CPR is the primary treatment for asystole, along with epinephrine and addressing reversible causes.

Incorrect. Amiodarone 300 mg IV/IO is administered after defibrillation and epinephrine to treat refractory VF or pulseless VT.

Incorrect. Atropine blocks vagal stimulation, increasing heart rate in cases of symptomatic bradycardia.

Incorrect. Synchronized cardioversion is used to restore a normal rhythm in unstable atrial fibrillation.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. The correct compression rate for CPR is 100-120 compressions per minute to optimize perfusion and prevent fatigue.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest that can be treated with fluid resuscitation to restore circulation.

Incorrect. Asystole is a non-shockable rhythm and is treated with high-quality CPR and epinephrine administration.

Incorrect. Interruptions in chest compressions should not exceed 10 seconds to maintain adequate perfusion to vital organs.

Incorrect. A sudden increase in PETCO2 is a reliable indicator of ROSC, reflecting improved circulation and gas exchange.

Incorrect. A compression fraction >80% ensures that the majority of CPR time is spent delivering chest compressions to improve outcomes.

Incorrect. Calcium gluconate stabilizes the cardiac membrane and reduces the risk of life-threatening arrhythmias caused by hyperkalemia.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. PEA is not a shockable rhythm; it is treated with CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. Epinephrine is administered to increase coronary and cerebral perfusion pressure during cardiac arrest.

Incorrect. Atropine is the first-line drug for treating symptomatic bradycardia by increasing heart rate through vagal inhibition.

Incorrect. Synchronized cardioversion is indicated for unstable atrial fibrillation to restore sinus rhythm and prevent hemodynamic collapse.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be treated with warming measures.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. Positioning the patient with a slight left tilt prevents aortocaval compression and improves venous return during CPR.

Incorrect. Immediate defibrillation is the most effective intervention for a witnessed cardiac arrest in VF.

Incorrect. Adenosine is the first-line drug for treating narrow-complex SVT by slowing conduction through the AV node.

Incorrect. Minimizes interruptions to maintain blood flow to vital organs.

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. Rotating team roles every 2 minutes prevents fatigue, ensuring consistent delivery of high-quality chest compressions.

Incorrect. Compressing one-third the depth of the chest ensures adequate perfusion while minimizing the risk of injury.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. Pulse checks are performed every 2 minutes during rhythm assessments to evaluate the effectiveness of resuscitation.

Incorrect. Activating EMS ensures help is on the way while you assess and initiate resuscitation.

Incorrect. Epinephrine 1 mg IV/IO is administered every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Pediatric defibrillation begins at 2 J/kg for the first shock and increases as necessary for subsequent shocks.

Incorrect. The initial dose of adenosine for stable SVT in adults is 6 mg IV, followed by 12 mg if needed for subsequent doses.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Compressing 2-2.4 inches ensures effective perfusion during adult CPR while minimizing the risk of injury.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. PETCO2 monitoring provides real-time feedback on ventilation and the effectiveness of chest compressions.

Incorrect. Stabilizes the myocardium and suppresses arrhythmias during refractory VF or pulseless VT.

Incorrect. Amiodarone is used after defibrillation and epinephrine for refractory VF to stabilize the myocardium.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. Early defibrillation is critical for survival, especially in shockable rhythms like VF/VT.

Incorrect. The two-thumb encircling technique provides high-quality compressions for infants during CPR.

Incorrect. Oxygenation and ventilation should be optimized to avoid hypoxia or hyperoxia during post-cardiac arrest care.

Incorrect. Defibrillation is the priority for VF and should not be delayed for drug administration, as it is the definitive treatment.

Incorrect. Early defibrillation within 30 seconds of a witnessed VF arrest increases survival rates significantly.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. Hypokalemia can cause cardiac arrhythmias and is included in the "H's" of reversible causes of cardiac arrest.

Incorrect. Optimal for maintaining adequate circulation without risking poor perfusion due to excessive speed.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be completed before checking the rhythm.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Delivering 1 breath every 5-6 seconds prevents hypoventilation or hyperventilation.

Incorrect. Defibrillation should be performed immediately after identifying VF, not delayed up to 10 minutes.

Incorrect. Pulse checks should be limited to 10 seconds to minimize interruptions in chest compressions.

Incorrect. Biphasic defibrillation begins at 120-200 J to terminate shockable rhythms like VF and pulseless VT effectively.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and is treated by warming the patient to improve outcomes.

Incorrect. Ventilation with an advanced airway should be provided at a rate of 1 breath every 6 seconds, or 10 breaths per minute.

Incorrect. The 15:2 ratio improves oxygenation and circulation during high-quality infant CPR performed by two rescuers.

Incorrect. Pulse checks during CPR should not exceed 10 seconds to minimize interruptions in chest compressions.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore an organized rhythm.

Incorrect. Adenosine 6 mg is given as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. Thrombosis (pulmonary or coronary) is a reversible cause of cardiac arrest and should be addressed immediately.